ACCC association of cancer care centers
Join/Renew
Login
Join/Renew
Login
Education & Resources
ACCC eXchange LogInCorporate Member Sponsored ResourcesPresentations & AbstractsPresident's ThemeACCC Connect eLearning LogIn
Publications
Oncology IssuesPatient Assistance & Reimbursement GuideTrending Now in Cancer Care
Events
2026 ACCC Leadership SummitAnnual Meeting & Cancer Center Business SummitCapitol Hill DayNational Oncology ConferenceOncology Reimbursement MeetingsOncology State Society Meetings
Policy & Advocacy
2024 Policy Wrap-Up and ACCC 2025 Policy PrioritiesLetters & StatementsAccess, Payment & Reimbursement ReformWhite Bagging & Brown BaggingAdvocacy ResourcesCancer Moonshot
Membership
Join | RenewWho We AreMembership Types & BenefitsCorporate MembersACCC Member Portal FAQMember Directory
Partners
Oncology State SocietiesPartner OrganizationsCME
News
News ReleasesAdvocacy News ReleasesOncology News
About ACCC
Timeline / 50th Anniversary2025 Impact ReportACCC Innovator AwardsACCC FellowsACCC Senior Staff
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
Join/Renew
Login
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
    • Education & Resources
    • Publications
    • Events
    • Policy & Advocacy
    • Membership
    • Partners
    • News
    • About ACCC
ACCC association of cancer care centers
1801 Research Boulevard, Suite 400, Rockville, MD 20850
Tel: 301.984.9496 Fax: 301.770.1949 Email Us
Contact UsVolunteers
Advertise
Career Center
Terms and Conditions
Privacy Policy
ACCC Rebranding
Copyright © 2026 Association of Cancer Care Centers. All Rights Reserved.
Home / Education And Resources / Patient Assistance And Reimbursement Guide / Companies / Bayer Healthcare Pharmaceuticals Inc

BAYER

Bayer

Access Service by Bayer™

Bayer HealthCare Pharmaceuticals, Inc. offers the Access Services by Bayer program for patients prescribed Nexavar, Nubeqa, Stivarga, or Vitrakvi. For more information, search the prescribed medication in this Guide; go to the Nexavar, Nubeqa, Stivarga, or Vitrakvi website; or call 1.800.288.8374, Monday through Friday, 9:00 AM to 6:00 PM EST.

Aliqopa Resource Connections

Bayer HealthCare Pharmaceuticals, Inc. offers the Aliqopa Resource Connections program for patients prescribed Aliqopa. For more information, search Aliqopa in this Guide, go online, or call 833.254.7572, Monday through Friday, 9:00 AM to 7:00 PM EST.

Xofigo Access Services

Bayer HealthCare Pharmaceuticals, Inc. offers the Xofigo Access Services program for patients prescribed Xofigo. For more information, search Xofigo in this Guide, go online, or call 1.855.696.3446, Monday through Friday, 9:00 AM to 7:00 PM EST.


Oncology-related products: Aliqopa™ (copanlisib) for injection, Nexavar® (sorafenib) tablets, Nubeqa® (darolutamide) tablets, Vitrakvi® (larotrectinib) capsules, Vitrakvi® (larotrectinib) oral solution, Xofigo® (radium Ra 223 dichloride) injection

Reimbursement Assistance

Access Services by Bayer™

Access Services by Bayer offers:

  • Benefit verification
  • Specialty pharmacy provider identification
  • Prior authorization information
  • Denial/appeal information.

Visit the Stivarga, Nexavar, Nubeqa, or Vitrakvi website for more information or call 1.800.288.8374, Monday through Friday, 9:00 AM to 6:00 PM EST.

Independent Charitable Foundations/Organizations

Access Services by Bayer™ Referrals

Service counselors can provide referrals to charitable foundations, including the Bayer U.S. Patient Assistance Foundation, that may be able to help patients with government-sponsored insurance with out-of-pocket costs. Patients who do or do not meet the requirements for Access Services by Bayer do not automatically qualify for financial help from charitable organizations.

For more information, visit the prescribed medication's dedicated website or call 1.800.288.8374, Monday through Friday, 9:00 AM to 6:00 PM EST.

Co-Pay Card/Out-Of-Pocket Cost Assistance

Aliqopa $0 Co-Pay Program

The Aliqopa $0 Co-Pay Program is for eligible patients with commercial insurance. Patients must not be enrolled in a government-sponsored program and must meet certain other eligibility criteria to qualify for this program. If approved, the patient may pay as little as $0, with a maximum benefit of $25,000 per year.

To enroll in the ARC Program, fax the completed enrollment form to 833.427.2329. For more information, call 833.254.7672, Monday through Friday, 9:00 AM to 7:00 PM EST.

Reimbursement Assistance

Aliqopa Resource Connections (ARC)

The Aliqopa Resource Connections (ARC) patient support program offers comprehensive access, reimbursement support, and patient assistance services, including:

  • Insurance benefit verifications
  • Prior authorization information (physician office must submit prior authorization)
  • Claims appeal information
  • Claims status
  • Billing and coding information
  • Payer policy information.

For more information, call 833.254.7672, Monday through Friday, 9:00 AM to 7:00 PM EST or visit the ARC program website.

Independent Charitable Foundations/Organizations

Aliqopa Resource Connections (ARC) Referrals

The Aliqopa Resource Connections (ARC) program offers referrals to independent assistance foundations for publicly insured patients and those requiring travel assistance.

Patients with Medicare or other government insurance who need assistance with the cost-share requirements for Aliqopa may be eligible for co-pay or coinsurance assistance through an independent co-pay assistance foundation. Access counselors can verify patients’ coverage for Aliqopa. If co-pay assistance needs are identified, the access counselor can provide information about any available foundations. The foundation will determine patients’ eligibility for co-pay or coinsurance assistance based on their own criteria and will contact the patient directly regarding the application process.

Patients may be eligible for travel assistance through an independent travel assistance foundation. Access counselors can provide information about any available foundations. The foundation will determine patients’ eligibility for travel and other supporting assistance based on their own criteria and will contact the patient directly regarding the application process.

To enroll in the ARC Program, fax the completed enrollment form to 833.427.2329. For more information, call 833.254.7672, Monday through Friday, 9:00 AM to 7:00 PM EST.

Insurance Coverage-Related Delay Program

ARC Temporary Patient Assistance Program

The Temporary Patient Assistance Program is for patients whose coverage is delayed or who experience a temporary lapse in coverage for Aliqopa.

To enroll in the ARC Program, fax the completed enrollment form to 833.427.2329. For more information, call 833.254.7672, Monday through Friday, 9:00 AM to 7:00 PM EST.

Patient Assistance Program

Bayer U.S. Patient Assistance Foundation

The Bayer U.S. Patient Assistance Foundation is a charitable organization that helps eligible patients get Bayer prescription medicine at no cost.

Patients may be eligible for the Bayer U.S. Patient Assistance Foundation if they:

  • Live in the United States or Puerto Rico
  • Meet certain income limits
  • Do not have insurance or if their Bayer prescription medicine is not covered.

To apply, fax the completed enrollment form to 1.866.575.6568. For questions, call 1.866.228.7723, Monday through Friday, 9:00 AM to 6:00 PM EST.

Co-Pay Card/Out-Of-Pocket Cost Assistance

Nubeqa $0 Co-Pay Program

Eligible, commercially insured patients may pay as little as $0 and save up to $25,000 per year. Patients who are enrolled in any type of government insurance or reimbursement programs are not eligible.

Annual auto enrollment helps avoid gaps in therapy. There are no income requirements.

Apply online. For questions, call 1.800.288.8374, Monday through Friday, 9:00 AM to 6:00 PM EST.

Insurance Coverage-Related Delay Program

Nubeqa Free Trial Program

The Nubeqa free trial program provides a one-month supply of Nubeqa at no cost to patients who meet the program eligibility requirements and agree to the terms and conditions.

For full terms and conditions and to enroll patients, call 1.800.288.8374 or visit the program website.

Co-Pay Card/Out-Of-Pocket Cost Assistance

Oncology $0 Co-Pay Program

For eligible, commercially insured patients prescribed Nexavar or Stivarga, the zero dollar co-pay program allows patients to fill their prescription with no out-of-pocket costs. Patients can receive up to $25,000 in savings with no monthly maximum.

To be eligible patients must:

  • Be a United States resident
  • Be over 18 years old
  • Currently have commercial health insurance for a portion of their prescription drug cost
  • Not be enrolled in any federal or state subsidized healthcare program that covers a portion of their prescription drug costs, including Medicare (such as Medicare Part D prescription drug benefit), Medicaid, TriCare, or any other federal or state healthcare plan, including pharmaceutical assistance programs.

Patient eligibility will be reassessed annually.

Enroll online by clicking on the prescribed medication. For questions about the co-pay program, call 1.866.581.4992.

Vitrakvi $0 Co-Pay Program

The Vitrakvi $0 Co-Pay Program is for eligible, commercially insured patients. Patients who are enrolled in any type of government insurance or reimbursement programs are not eligible.

To enroll and for more information, go online or call 1.800.288.8374, Monday through Friday, 9:00 AM to 6:00 PM EST.

Xofigo $0 Commercial Co-pay Assistance Program

Patients may be eligible for co-payment/coinsurance assistance if they have a private commercial plan that covers Xofigo. Patients approved for assistance will not have to pay anything to access Xofigo. If patients have public insurance (e.g., Medicare or other government payors, such as the Department of Veterans Affairs and Department of Defense), they are not eligible.

Eligibility criteria include:

  • Patient has private commercial insurance.
  • Patient resides in the United States, including D.C., Puerto Rico, Guam, or the U.S. Virgin Islands.

To apply, fax a completed application, including the signed patient authorization, to 1.855.963.4463. Once approved, patients will receive an approval letter with a commercial co-pay/coinsurance identification card.

Registered healthcare providers can also request patient financial assistance Xofigo Access Services Provider Portal.

For more information, call 1.855.696.3446, Monday through Friday, 9:00 AM to 7:00 PM EST.

Reimbursement Assistance

Xofigo Access Services

Xofigo Access Services assists healthcare professionals with:

  • Initiating a new patient intake
  • Requesting a benefits verification
  • Requesting patient financial assistance
  • Receiving alerts and reminders
  • Confirming a Xofigo order has shipped.

Healthcare professionals can access these services online 24/7 through the Xofigo Access Services Provider Portal. For more information, call 1.855.696.3446, Monday through Friday, 9:00 AM to 7:00 PM EST.

Patient Assistance Program

Xofigo Patient Assistance Program

Xofigo Access Services may provide Xofigo free of charge for eligible patients who are uninsured or who are insured but do not have coverage for Xofigo. Eligibility criteria include:

  • Financial criteria based on adjusted gross household income (documentation of income is required)
  • Residency in the United States, including D.C., Puerto Rico, Guam, or the U.S. Virgin Islands.

To enroll, fax the completed application, including the signed patient authorization, to 1.855.963.4463. Registered healthcare providers can also request patient financial assistance Xofigo Access Services Provider Portal.

For more information, call 1.855.696.3446, Monday through Friday, 9:00 AM to 7:00 PM EST.

Independent Charitable Foundations/Organizations

Xofigo Referrals

If patients with public insurance need assistance with their cost-share requirements for Xofigo, they may be eligible for co-pay or coinsurance assistance through an independent co-pay/coinsurance assistance foundation.

If co-pay assistance needs are identified, an access counselor can provide information about any available foundation. The foundation will determine patients’ eligibility for co-pay or coinsurance assistance based on their own criteria.

For more information, call 1.855.696.3446, Monday through Friday, 9:00 AM to 7:00 PM EST.